Announced Wed, 30 Sept, 2026 · 20:13 IST

Trading window closed ahead of Q2 FY2027 results

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹25.99

prior close

₹25.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.2% vs market

Pharmaceuticals peers, median of 173sector-0.8%+0.7% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.4

10m

+4.0

15m

+4.0

30m

-3.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1-1.3+1.2-0.8+0.7

Next day

-4.4-1.3-3.1-1.2-3.2

-3.8+0.0-3.8-0.4-3.4

-1.7-0.2-1.5-0.1-1.6

-2.8-3.0+0.1-3.1+0.2

+1.6-2.7+4.3-3.1+4.7

-3.8-1.7-2.1-3.0-0.8

15d

-4.3-8.9+4.6-7.1+2.8

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Beryl Drugs has closed its trading window from 1 October 2026 until 48 hours after the board declares unaudited financial results for the quarter ended 30 September 2026. The closure applies to board members, promoters, and designated persons, as per SEBI insider trading norms. The board meeting date for results announcement will be communicated later.

Likely market impact

Routine insider trading closure ahead of quarterly results; no direct price impact expected, but signals upcoming earnings announcement.